News & More

TympaHealt provides a solution that enables fully digitized assessments of ear and hearing health to be performed in both traditional and community-based clinical settings. The Tympa Platform allows a broad range of professionals to perform digital otoscopy, microsuction wax removal, and hearing assessments. The company intends to use the funds to grow its team and services in the UK, across Europe and enter into the US.

According to SkyQuest, the market's growth will be significant due to factors such as the aging population, chronic diseases, government initiatives, cost-effectiveness, and technological advancements. Furthermore, the report states that Europe's aging population is expected to exceed 150 million by 2050, leading to increased demand for home healthcare services as elderly individuals prefer to receive care at their own homes. The report also reveals that home healthcare services can reduce healthcare costs by up to 30% compared to hospitalization or institutional care.

Regulatory mandates encouraging the implementation of digital health strategies have increased EHR adoption, which has aided the growth of the patient portal market. The patient portal market has grown in popularity as a result of government agencies' push for database interoperability and the ease of use provided by EHR in increasing patient engagement. Furthermore, as the number of projects in developing countries grows, so will the demand for patient portals.

The new fund, called Gilde Healthcare Venture&Growth VI, focuses on fast-growing companies developing solutions for better care at a lower cost. Gilde Healthcare invests in companies in Europe and North America active in digital healthcare, medical technology (MedTech) and therapeutics. The fund is backed by a balanced mix of international investors, including corporates, banks, pension funds, insurers, fund-of-funds, sovereign wealth funds, endowments, family offices, entrepreneurs and the Gilde team.

New investment comes from existing VC backers as the company configures for Series A funding. The successful close demonstrates ongoing confidence in Zetta Genomics and its transformational XetaBase platform - to unlock the improved research, medical and healthcare outcomes of genomics at scale.

According to the report published by Virtue Market Research, the Global Digital Behavioural Health Market was valued at $106.93 billion in 2022, and is projected to grow at a CAGR of 29% over the forecast period of 2023-2030. The increasing focus on patient empowerment and self-management is expected to drive the growth of the Digital Behavioural Health Market in Europe in the coming years.

Global mobile health apps market value is projected at $68.26 billion in 2023 and is expected to grow at a CAGR Of 18.1% by 2033. Europe is the second-largest market for mobile health apps, with countries like the United Kingdom, Germany and France leading the charge. This region boasts a high population of smartphone users, rising healthcare costs and an acute shortage of healthcare professionals - factors driving demand for these applications.

According to a new report by Grand View Research, digital health market is expected to expand at a CAGR of 18.6% during the forecast period. Rising smartphone adoption, improved internet connectivity with the launching of 4G/5G, advancement in healthcare IT infrastructure, rising healthcare costs, the rising penetration rate of chronic diseases, increasing adoption rate of remote patient monitoring services, and rising accessibility of virtual care are some of the major factors that fuel the industry growth.

Teton's AI solution will give nurses the tools to monitor patients in real time and help them to stay on top of paperwork. The AI assistant acts as an extra pair of eyes and ears as smart cameras scan the wards for updates and patient activity, which is then fed back into a web app to update the nurses of any changes.

With the acquisition, Phlo is purchasing Truepill's partnerships with several UK digital healthcare providers, such as The Lowdown, Levels, Daye, Hanx, and Veri as well as the company's tech stack, including the full set of APIs and prescribing technology. Phlo Digital Pharmacy is currently available in Birmingham and London, and is expected to expand to Manchester later this year.